Related Experiment Video
Updated: Aug 19, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Vancomycin pharmacokinetics in patients undergoing chronic intermittent peritoneal dialysis
Abstract:
The pharmacokinetics of vancomycin were studied during six episodes of peritonitis in four patients with chronic renal failure managed with chronic intermittent peritoneal dialysis. Following intravenous administration of vancomycin peritoneal concentrations ranged from undetectable to 22.5 micrograms/ml, and were 0-96% (mean 27%) of simultaneous serum concentrations. In view of the unpredictable penetration of vancomycin from serum into peritoneal fluid, we recommend that therapy for peritonitis due to staphylococci in patients undergoing peritoneal dialysis should include intraperitoneal administration of vancomycin.
Related Concept Videos
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Estimation of k and VD of Aminoglycosides
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

